In our continuing commitment to provide innovative laboratory services for patients and physicians, John Muir Health and MuirLab are pleased to offer the next evolution in HIV-1 viral load testing, the COBASĀ® AmliPrep/Taqman HIV-1 test by Roche Diagnostics. This FDA-approved real time PCR is the first in the U.S. to offer full automation sample preparation, amplification and quantitation and delivers full Group M subtype coverage, including the rare non-B subtypes.
The dynamic range of this test delivers standard of care sensitivity and quantitation between 48 copies and 10,000,000 copies. In addition, there is no need to re-baseline or recalibrate patients because a high correlation between this test and other HIV-1 viral load methodologies (including branched-chain DNA assays) has been demonstrated. These studies are available upon request.
If there are any questions, please do hesitate to contact Nick Byrne, M.D. (925) 947-5390, Barry Latner, M.D. (925) 692-5405 or Cindy Liedstrand, Supervisor Molecular Testing, (925) 692-5681.